Parkinson’s disease is a neurological condition that impacts movement. Initial symptoms involve shaking, diminished sense of smell and difficulties with coordination.
The exact cause of Parkinson’s disease remains unclear but current theories suggest that genetic alterations and interactions with the environment, such as exposure to harmful substances, may significantly contribute to its onset.
In a new study, published in Molecular Psychiatry, researchers from the University of Copenhagen, in Denmark, explain how mitochondria, which are essential energy factories in brain cells, especially neurons, experience damage and could be implicated in the disease.
This damage leads to problems in the mitochondrial DNA, which then spreads the disease throughout the brain rapidly.
The researchers point out that their study confirms that the transmission of this damaged genetic material results in symptoms similar to Parkinson’s and its evolution into dementia.
Lead author Prof. Shohreh Issazadeh-Navikas, group leader for Neuroinflammation Unit, Director of MoMeD PhD School, Faculty of Health and Medical Sciences at the University of Copenhagen, Denmark, spoke to Medical News Today about the study.
“We show that brain cells chop off parts of their own genetic material (mitochondrial DNA) and spit it out of the cells, this is taken up by other neighboring cells,” Prof. Issazadeh-Navikas explained.
“In this way, this damaged genetic material makes the new cell sick and thereby disease spreads like a wildfire,” she added.
“Normally antiviral genes help the brain cells to prevent the disease to start and spread. But if brain cells do not have good antiviral responses, then the disease can start,” Prof. Issazadeh-Navikas pointed out.
New Parkinson’s biomarker would be a game-changer
Biomarkers, which are tangible signs of specific health conditions in patients, can vary from commonly measured attributes like blood pressure and body temperature to more disease-specific indicators, such as genetic mutations in cancer or glucose levels for diabetes.
For example, based on this new research, there is a chance that damaged mitochondrial DNA in brain cells might seep into the bloodstream.
If this is the case, it could be possible to use a simple blood sample from a patient for early diagnosis or to monitor the effectiveness of upcoming treatments.
Prof. Issazadeh-Navikas highlighted that this could be a future possibility:
“The first step is to check small blood samples from patients with Parkinson and healthy individuals to make sure the damaged genetic materials are selective for Parkinson’s patients. This can help to diagnose Parkinson’s patients and the stages of their disease progression (as biomarker). The biomarker can help to check the treatment effects. The new knowledge can help to develop new drugs.”
– Medical News Today
Written by: Paul Ian Cross, PhD
Fact checked by:Sarah Myers, PharmD
Have researchers just found another cause of Parkinson’s disease?